ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

INMD InMode Ltd

18.405
-0.095 (-0.51%)
Last Updated: 20:32:44
Delayed by 15 minutes
Share Name Share Symbol Market Type
InMode Ltd NASDAQ:INMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.095 -0.51% 18.405 18.40 18.41 18.54 18.18 18.27 769,318 20:32:44

InMode Ltd. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 15, 2024 to Discuss Your Rights - INMD

11/03/2024 9:55am

PR Newswire (US)


InMode (NASDAQ:INMD)
Historical Stock Chart


From Mar 2024 to May 2024

Click Here for more InMode Charts.

NEW YORK, March 11, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of InMode Ltd..

The Gross Law Firm (PRNewsfoto/The Gross Law Firm)

Shareholders who purchased shares of INMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/inmode-loss-submission-form/?id=70015&from=4

CLASS PERIOD: June 4, 2021 to October 12, 2023

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) InMode heavily discounts almost every device it sells; (ii) demand for InMode's products was driven by InMode's willingness to discount its products; (iii) InMode violated U.S. Food and Drug Administration ("FDA") regulations by engaging in off-label marketing and promoting products for treatment of indications for which they lack FDA approval; and (iv) InMode violated FDA regulations by failing to timely report injuries caused by its devices.

DEADLINE: April 15, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/inmode-loss-submission-form/?id=70015&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of INMD during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 15, 2024. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-ltd-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-april-15-2024-to-discuss-your-rights--inmd-302084448.html

SOURCE The Gross Law Firm

Copyright 2024 PR Newswire

1 Year InMode Chart

1 Year InMode Chart

1 Month InMode Chart

1 Month InMode Chart

Your Recent History

Delayed Upgrade Clock